Aarkstore - Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

1
Aarkstore - Moderate Pain-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
Category Pharmaceuticals and Healthcare
2
Moderate Pain-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2015, Report
provides comprehensive insights about phase III
pipeline drugs and marketed drugs across the
Moderate Pain. A key objective of DelveInsights
report is to establish the understanding for API
Manufacturers for marketed and Phase III Pipeline
drugs across the different countries and regions
for the drugs falling under Moderate Pain. The
Report gives insights into patents providing the
patent protection data and marketing exclusivity
of all the drugs across the Moderate Pain. While
the leading brands, companies and chemicals are
considered thoroughly, DelveInsights report also
provides details on the Global API Manufacturers
across the globe covering Drug Master Filings of
US, Europe and API Manufacturers in Asia
specifically China and India. The research
analysis also presents the global sales forecasts
data till 2016.
Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/97799/moderate-pain-gl
obal-api-manufacturers-marketed-and-phase-iii-drug
s-landscape-2015
3
Data Sources

• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.
• Secondary sources information and data has been
  collected from various printable and
  non-printable sources like search engines, News
  websites, Government Websites, Trade Journals,
  White papers, Magazines, Trade associations,
  Books, Industry Portals, Industry Associations
  and access to available databases.
• Please noteThis report requires certain updates.
  We have all the information available but require
  3 business days to complete the process and
  ensure it is as up-to-date as possible. Certain
  sections in the report may be removed or altered
  based on the availability and relevance of data
  for the indicated disease.
• .

4
Scope

• A snapshot of the global Market therapeutics
  scenario for Moderate Pain.
• A review of the marketed products under
  prescription for Moderate Pain, regulatory
  information and marketing status.
• Coverage of global patent coverage and detailed
  commentaries on the US patent challenges.
• Graphical representation of investigational
  products for patent expiry and market
  exclusivities across the globe.
• Product profiles for marketed products for
  Moderate Pain with complete description of
  mechanism of action, therapeutic class, target,
  route(s) of administration and chemical details.
• Coverage of API Manufacturers for Moderate Pain
  drugs in the United States, Europe and Asian
  Regions with location details.
• Coverage of Regulatory filings in theUS, Europe,
  and Asia specifically India and China for
  Moderate Pain drugs.
• Coverage of Route of Synthesis of Active
  Pharmaceutical Ingredient associated with
  Moderate Pain drugs.

5
Reasons to buy

• Evaluate the marketing status and exclusivity
  details of Moderate Pain key products to exploit
  opportunities for generic drug development
  opportunities.
• Identify and understand important and diverse
  types of therapeutics under Phase III development
  for Moderate Pain.
• Design effective counter-strategies to gain
  competitive advantage by identifying the key
  patent expiry details and exclusivity with
  respect to Moderate Pain.
• API intelligence over marketed drugs for Moderate
  Pain and gaining primary intelligence over active
  ingredients manufacturers across the globe.
• API intelligence over leading Phase III Pipeline
  drugs.
• Develop and design strategies by identifying the
  API manufacturers for Phase III Pipeline products
  to enhance and expand business potential and
  scope.

6
Table of Content

• Indication Overview
• Marketed Drugs
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing
  Status
• Marketed Details of Drugs by Patent Expiration
  Timeline
• Active Pharmaceutical Ingredient (API)
  Manufacturers Assessment
• API Manufacturers by United States Drug Master
  File (US DMF) Status
• API Manufacturers by US DMF Status (Drug
  Specific)
• API Manufacturers in Europe by Country
• API Manufacturers in India by State
• API Manufacturers in China by Province
• Marketed Details of Approved Drugs by Geography
• Active Pharmaceutical Ingredient (API)
  Manufacturers Assessment for Phase III Pipeline
  Drugs

7
List of Tables

• Moderate Pain Therapeutic Market, US, Marketed
  Drugs by Application Type, 2015
• Moderate Pain Therapeutic Market, US, Marketed
  Drugs by Marketing Status, 2015
• Moderate Pain Therapeutic Market, US, (Year),
  2015
• Moderate Pain Marketed Drugs, API Manufacturers
  by US DMF Status, 2015
• Moderate Pain Marketed Drugs, US DMF Status Drug
  Specific (Number), 2015
• Moderate Pain Drugs, API Manufacturers, Europe by
  Country, 2015
• Moderate Pain Drugs, API Manufacturers, India by
  State, 2015
• Moderate Pain Drugs, API Manufacturers, China by
  Province, 2015
• Moderate Pain Drugs, API Manufacturers by
  Geography 2015
• Moderate Pain Phase III Pipeline Drugs, US DMF
  Status Drug Specific (Number), 2015
• Moderate Pain Therapeutic Market, Global Sales
  2012-2016 (in million USD)
• API Manufacturers for Drug, 2015
•  
•  

8
List of Figures

• Moderate Pain Therapeutic Market, US, Marketed
  Drugs by Application Type (), 2015
• Moderate Pain Therapeutic Market, US, Marketed
  Drugs by Marketing Status (), 2015
• Moderate Pain Therapeutic Market, US, (Year),
  2015
• Moderate Pain Marketed Drugs, API Manufacturers
  by US DMF Status (), 2015
• Moderate Pain Marketed Drugs, US DMF Status Drug
  Specific (Number), 2015
• Moderate Pain Drugs, API Manufacturers, Europe by
  Country, 2015
• Moderate Pain Drugs, API Manufacturers, India by
  State, 2015
• Moderate Pain Drugs, API Manufacturers, China by
  Province, 2015
• Moderate Pain Drugs, API Manufacturers by
  Geography 2015

9
Related reports

•  
• Global Crohns Disease (CD) Market 2015-2019
• Global Chronic Kidney Disease (CKD) Drugs Market
  2015-2019
• Global Acquired Orphan Blood Diseases
  Therapeutics Market 2015-2019
• Womens Health - Assessing the Need for a
  Targeted and Specialized Approach
• Global Travel Vaccines Market 2015-2019
• Global Acquired Orphan Blood Diseases
  Therapeutics Market 2015-2019
• Patient Monitoring and Diagnostic Systems Markets
  in China
• Hearing Aids Markets in China
• Medical Imaging System and Equipment Markets in
  China 
• Medical Devices Markets in China

10

• Moderate Pain-Global API Manufacturers, Marketed
  and Phase III Drugs Landscape, 2015
• Published Feb 2015 100 Pages
• Moderate Pain-Global API Manufacturers, Marketed
  and Phase III Drugs Landscape, 2015, Report
  provides comprehensive insights about phase III
  pipeline drugs and marketed drugs across the
  Moderate Pain.
• Price

Format Price
PDF 2000
Site License 4000
Enterprise Wide License 6000
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news